ÂÜÀòÂÒÂ×

Nicola Carriglio currently serves as the Molecular Clinical Affairs Manager at Luminex Corporation, a DiaSorin Company, since January 2022. Previously, Nicola held the position of Corporate Clinical Studies Manager at DiaSorin from October 2018 to January 2022, where responsibilities included leading clinical studies in Europe, managing project timelines, and ensuring compliance with regulatory standards. Prior experience includes serving as a Project Manager at San Raffaele Hospital's GLP SR-TIGET Test Facility from January 2014 to September 2018, focusing on preclinical studies for advanced therapy medicinal products. Nicola holds a Ph.D. in Immunology and Applied Biotechnology from the University of Rome Tor Vergata and a Laurea Specialistica in Biotecnologie Mediche Farmaceutiche from Università degli Studi di Ferrara.